The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus: The Development and Application of a Lifestyle Intervention Based on Health Belief Model Supported by Mobile Health
Status: Recruiting
Location: See location...
Intervention Type: Device, Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to examine the effects of a lifestyle intervention based on a health belief model (HBM) supported by mobile health (mHealth) and the impact of continuous glucose monitoring (CGM) on maternal glycemic parameters, cardiometabolic risk, health behavior and infant's outcomes among women diagnosed with gestational diabetes mellitus (GDM).
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Aged 18 years or above
• Pregnant women diagnosed with gestational diabetes mellitus
• Willing to participate in the study
Locations
Other Locations
Taiwan
National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
RECRUITING
Hsinchu
Contact Information
Primary
HUNG-HUI CHEN, PhD
hunghuichen@ntu.edu.tw
886-2-2394-7109
Time Frame
Start Date: 2024-11-11
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 120
Treatments
Other: Controlled group-Blood glucose meters (BGM) group
The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.~Participants are required to use blood glucose meters (BGM) at 24-32 weeks of pregnancy and 33 weeks to before delivery. After 7-14 days of glucose monitoring at 24-32 weeks of pregnancy, glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at 33 weeks to before delivery , another glucose monitor reports will be given to the participants.
Experimental: Experimental group1-Continuous glucose monitoring (CGM) group
The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.~Participants will receive a set of continuous glucose monitor (CGM) respectively at 24-32 weeks of pregnancy (first set) and 33 weeks of pregnancy to before delivery (second set). After 7-14 days of glucose monitoring at 24-32 weeks of pregnancy, glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at 33 weeks to before delivery , another glucose monitor reports will be given to the participants.
Experimental: Experimental group2-Continuous glucose monitoring (CGM) with nursing care group
The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.~Participants will receive a set of continuous glucose monitor (CGM) respectively at 24-32 weeks of pregnancy (first set) and 33 weeks of pregnancy to before delivery (second set). After 7-14 days of glucose monitoring at 24-32 weeks of pregnancy, glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at 33 weeks to before delivery , another glucose monitor reports will be given to the participants.~Participants will receive nursing care for gestational diabetes at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum.
Related Therapeutic Areas
Sponsors
Leads: National Taiwan University Hospital